ChemShorts

This record is a retraction notice.

Pharmaceuticals (Basel, Switzerland) · ·Added 12 Nov 2026

RETRACTED: Hassanin et al. Design and Synthesis of New Hydantoin Acetanilide Derivatives as Anti-NSCLC Targeting EGFRL858R/T790M Mutations. Pharmaceuticals 2022, 15, 857.

Moamen A Hassanin, Muhamad Mustafa, Mohammed A S Abourehab, Heba A Hassan, Omar M Aly, Eman A M Beshr

DOI ↗

Abstract

The journal retracts the article titled "Design and Synthesis of New Hydantoin Acetanilide Derivatives as Anti-NSCLC Targeting EGFRL858R/T790M Mutations" [...].

Abstract as supplied by the indexing source. © the authors / publisher.